Private Sector Involvement

  • Your Selections:

Refine Results

date

Tags

NIH Experimental Ebola Vaccine Trial Begins; Other Vaccines, Treatments Under Development

News outlets report on various aspects of Ebola vaccine and treatment development and delivery. ABC News: Two Women Receive Experimental Ebola Vaccine in Fast-Tracked Trial “The first two doses of an experimental Ebola vaccine have been injected into human subjects in the National Institutes of Health’s fast-tracked clinical trial…” (Lupkin,…

Devex Reporters Discuss Public-Private Partnerships In U.S. Foreign Aid

Devex features a YouTube video with commentary from Michael Igoe, global development reporter at Devex, and Adva Saldinger, Devex Impact reporter, regarding a recent panel at the Wilson Center discussing the value of public-private partnerships for U.S. foreign aid. They highlight comments from USAID Administrator Rajiv Shah, who said the…

Service Delivery Must Be Evaluated To Achieve Improved Health Outcomes

In the Bill & Melinda Gates Foundation’s “Impatient Optimists” blog, Dana Hovig, director of integrated delivery at the foundation, discusses service delivery strengthening and writes that in order “to do this work well, we need to deeply understand the context in which we work, help demand intersect with the supply…

Hepatitis C Drugs Should Be More Accessible For World’s Poorest

The Guardian: Hepatitis C medicines must be made accessible faster than HIV drugs were Philippe Douste-Blazy, chair of UNITAID and special adviser to the U.N. secretary general on innovative financing “… Until recently, the only cure for hepatitis C involved an expensive combination of injections and tablets that lasted a…

Public-Private Partnership Brings Drugs, Essential Medical Supplies To Remote Areas

Huffington Post: Going the Extra Mile for Health Wendy Taylor, director of the Center for Accelerating Innovation and Impact at USAID, and Michael Goltzman, vice president of international government relations & public affairs at the CocaCola Company “…Five years ago, the Global Fund to Fight AIDS, Tuberculosis and Malaria turned…

U.S., Pharmaceutical Companies Should Work With, Not Against, Indian Drug Industry

SciDev.Net: Focus on Private Sector: India’s generic drug wars Maha Rafi Atal, PhD candidate at the University of Cambridge “…Indian companies provide cheap generic drugs to countries across the world and account for 80 percent of donor-funded HIV treatment — a set-up now threatened by U.S. pressure [to introduce ‘data…

TB Eradication Possible With Proper Health Care Systems, Diagnostic Tests, Vaccines, Funding

Project Syndicate: Taking the Offensive Against Tuberculosis Gunilla K√§llenius, professor of clinical microbiology at Karolinska Institutet “…[T]he world now has a narrow window of opportunity to eradicate TB. Taking advantage of it will require the rapid development and dissemination of effective diagnostic tools, novel drug treatments, and innovative vaccines, in…

New Report Calls On U.N. To Include Global Health R&D Indicators In SDG Monitoring Framework

Blog posts discuss a new report commissioned by a coalition of health nonprofits, titled “Measuring Global Health R&D for the Post-2015 Development Agenda.” Center for Global Health Policy’s “Science Speaks”: Development goals should include measures of global health research, report argues Rabita Aziz, policy research coordinator for the Center for…

Private Sector Can Help Fill Gaps In Vulnerable Nations’ Public Health Care Infrastructures

The Guardian: In global health care, quality and access are what matters — not who delivers it Joanna Buckley and Serufusa Sekidde, development economists at Oxford Policy Management “…Given their vulnerability, fragile and conflict-affected states simply do not have access to the large amounts of state expenditure needed to provide…